XML 62 R42.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Segment Reporting [Abstract] |
Net Sales and Operating Profit by Segment |
| 2024
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net (3) | Operating Profit
Reportable Segments |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |
North America(1) | $ | 4,113 |  | $ | 1,571 |  | $ | 1,668 |  | $ | 36 |  | $ | 839 |
Latin America | 4,782 |  | 1,933 |  | 1,328 |  | (5) |  | 1,526 |
Europe | 2,770 |  | 1,050 |  | 1,031 |  | 31 |  | 658 |
Asia Pacific | 2,858 |  | 1,078 |  | 997 |  | (30) |  | 812 |
Africa/Eurasia | 1,095 |  | 432 |  | 395 |  | 16 |  | 253 |
Total Oral, Personal and Home Care | 15,618 |  |  |  |  | 4,088 |
Pet Nutrition(2) | 4,483 |  | 1,869 |  | 1,641 |  | 8 |  | 965 |
Reconciliation with Total Company Operating Profit |  |  |  |  |
Corporate |  |  |  |  | (784) |
Total | $ | 20,101 |  |  |  |  | $ | 4,268 |
Note: Table may not sum due to rounding. (1) Net sales in the U.S. for Oral, Personal and Home Care were $3,640 in 2024. (2) Net sales in the U.S. for Pet Nutrition were $3,059 in 2024. (3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.
| 2023
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net (3) | Operating Profit
Reportable Segments |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |
North America(1) | $ | 4,091 |  | $ | 1,588 |  | $ | 1,594 |  | $ | 37 |  | $ | 871 |
Latin America | 4,640 |  | 1,977 |  | 1,241 |  | 5 | 1,417 |
Europe | 2,571 |  | 1,069 |  | 899 |  | 31 |  | 573 |
Asia Pacific | 2,782 |  | 1,108 |  | 925 |  | (18) |  | 767 |
Africa/Eurasia | 1,083 |  | 442 |  | 377 |  | 9 |  | 254 |
Total Oral, Personal and Home Care | 15,167 |  |  |  |  | 3,882 |
Pet Nutrition(2) | 4,290 |  | 1,964 |  | 1,493 |  | 26 | 806 |
Reconciliation with Total Company Operating Profit |  |  |  |  |
Corporate |  |  |  |  | $ | (704) |
Total | $ | 19,457 |  |  |  |  | $ | 3,984 |
Note: Table may not sum due to rounding. (1) Net sales in the U.S. for Oral, Personal and Home Care were $3,625 in 2023. (2) Net sales in the U.S. for Pet Nutrition were $2,918 in 2023. (3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.
| 2022
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net (3) | Operating Profit
Reportable Segments |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |
North America(1) | $ | 4,002 |  | $ | 1,649 |  | $ | 1,567 |  | $ | 46 |  | $ | 741 |
Latin America | 3,982 |  | 1,885 |  | 1,059 |  | (71) |  | 1,108 |
Europe | 2,362 |  | 1,023 |  | 778 |  | 28 |  | 534 |
Asia Pacific | 2,826 |  | 1,160 |  | 954 |  | (24) |  | 737 |
Africa/Eurasia | 1,082 |  | 447 |  | 389 |  | 18 |  | 228 |
Total Oral, Personal and Home Care | 14,254 |  |  |  |  | 3,348 |
Pet Nutrition(2) | 3,713 |  | 1,569 |  | 1,287 |  | 7 | 850 |
Reconciliation with Total Company Operating Profit |  |  |  |  |
Corporate |  |  |  |  | $ | (1,305) |
Total | $ | 17,967 |  |  |  |  | $ | 2,893 |
Note: Table may not sum due to rounding. (1) Net sales in the U.S. for Oral, Personal and Home Care were $3,511 in 2022. (2) Net sales in the U.S. for Pet Nutrition were $2,432 in 2022 (3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.
|  | 2024 |  | 2023 |  | 2022
Capital expenditures |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 52 |  |  | $ | 46 |  |  | $ | 66 |
Latin America |  | 126 |  |  | 146 |  |  | 121 |
Europe |  | 63 |  |  | 44 |  |  | 31 |
Asia Pacific |  | 64 |  |  | 65 |  |  | 60 |
Africa/Eurasia |  | 12 |  |  | 10 |  |  | 30 |
Total Oral, Personal and Home Care |  | 317 |  |  | 311 |  |  | 308 |
Pet Nutrition |  | 143 |  |  | 301 |  |  | 297 |
Corporate |  | 101 |  |  | 93 |  |  | 91 |
Total Capital expenditures |  | $ | 561 |  |  | $ | 705 |  |  | $ | 696 |
|  | 2024 |  | 2023 |  | 2022 |
Depreciation and amortization |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |
North America |  | $ | 124 |  |  | $ | 116 |  |  | $ | 128 |  |
Latin America |  | 100 |  |  | 98 |  |  | 93 |  |
Europe |  | 65 |  |  | 65 |  |  | 68 |  |
Asia Pacific |  | 81 |  |  | 84 |  |  | 89 |  |
Africa/Eurasia |  | 8 |  |  | 9 |  |  | 9 |  |
Total Oral, Personal and Home Care |  | 378 |  |  | 372 |  |  | 387 |  |
Pet Nutrition |  | 132 |  |  | 101 |  |  | 65 |  |
Corporate |  | 95 |  |  | 94 |  |  | 93 |  |
Total Depreciation and amortization |  | $ | 605 |  |  | $ | 567 |  |  | $ | 545 |  |
|  | 2024 |  | 2023 |  |
Long-lived assets(1) |  |  |  |  |  |
United States |  | $ | 2,728 |  |  | $ | 2,733 |  |  |
International |  | 2,223 |  |  | 2,340 |  |  |
Total Long-lived assets |  | $ | 4,951 |  |  | $ | 5,073 |  |  |
(1) Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration